A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?
about
The 2013–2016 Ebola epidemic: multidisciplinary success conceals a missed opportunityHerd Immunity to Ebolaviruses Is Not a Realistic Target for Current Vaccination Strategies.Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola VirusIntradermal immunization by Ebola virus GP subunit vaccines using microneedle patches protects mice against lethal EBOV challenge
P2860
A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?
description
2017 nî lūn-bûn
@nan
2017 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
A review of Phase I trials of ...... ace to develop novel vaccines?
@ast
A review of Phase I trials of ...... ace to develop novel vaccines?
@en
type
label
A review of Phase I trials of ...... ace to develop novel vaccines?
@ast
A review of Phase I trials of ...... ace to develop novel vaccines?
@en
prefLabel
A review of Phase I trials of ...... ace to develop novel vaccines?
@ast
A review of Phase I trials of ...... ace to develop novel vaccines?
@en
P2860
P50
P921
P356
P1476
A review of Phase I trials of ...... ace to develop novel vaccines?
@en
P2093
Katie J Ewer
P2860
P304
P356
10.1098/RSTB.2016.0295
P407
P5008
P577
2017-05-01T00:00:00Z